Metabolic Assessment of Gliomas Using¹¹C-Methionine, [¹⁸F] Fluorodeoxyglucose, and¹¹C-Choline Positron-Emission Tomography

1995, Radiology, 195, 47, 10.1148/radiology.195.1.7892494

10.1097/00006123-198911000-00006

1998, Neurology, 50, 1316, 10.1212/WNL.50.5.1316

1998, J Nucl Med, 39, 778

10.3171/jns.2001.95.5.0746

10.1007/s00259-004-1598-6

1982, Neurology, 32, 1323, 10.1212/WNL.32.12.1323

1996, AJNR Am J Neuroradiol, 17, 345

10.1007/s00259-005-0044-8

10.1007/s00259-002-0880-8

2001, J Nucl Med, 42, 9

2000, Clin Cancer Res, 6, 3837

2004, Eur J Nucl Med Mol Imaging, 31, 1064

10.1007/s002590100620

1997, J Nucl Med, 38, 842

10.1023/A:1023342516925

10.1023/A:1006206920822

1997, Can J Neurol Sci, 24, 313, 10.1017/S0317167100032984

10.1093/jnci/90.19.1473

1992, Neurosurgery, 31, 78

1991, Radiology, 181, 731, 10.1148/radiology.181.3.1947089

10.1016/S1536-1632(01)00010-5

10.1097/00006123-199702000-00009

10.1007/BF00165590

10.1111/j.1750-3639.1994.tb00835.x

10.1002/glia.440150313

1999, Am J Pathol, 154, 581, 10.1016/S0002-9440(10)65303-5

10.1007/s00259-003-1148-7

10.1023/B:NEON.0000033384.43417.82

10.3171/jns.2005.103.3.0498

2003, J Neurosurg, 99, 474, 10.3171/jns.2003.99.3.0474

10.1136/jnnp.2003.028480

2004, J Nucl Med, 45, 1146

10.3171/jns.2006.104.2.238